Showing results (11-20 of 6,995) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|November 2, 2015
Is there a specific phenotype associated with the different subtypes of KRAS mutations in patients with advanced non-small-cell lung cancers?Coraline Dumenil, Thibault Vieira, Etienne Rouleau, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2016
CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer modelsFernando Benavent Acero, Carla S Capobianco, Juan Garona, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2016
Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PETI Bahce, M Yaqub, E F Smit, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2016
Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapyMarco Tomasetti, Monica Amati, Jiri Neuzil, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2016
Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencingBrett Doble, Thomas John, David Thomas, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): Results of a multicenter prospective studyKazuo Nakagawa, Hisao Asamura, Koji Tsuta, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy"Juliane Rieber, Jan Streblow, Lorenz Uhlmann, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in BrazilGuilherme Costa, Luiz Claudio Santos Thuler, Carlos Gil Ferreira
Lung Cancer (Amsterdam, Netherlands)|August 13, 2015
Increased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancerAlexandra Giatromanolaki, Dimitra Kalamida, Efthimios Sivridis, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Nintedanib (BIBF 1120) blocks the tumor promoting signals of lung fibroblast soluble microenvironmentGali Epstein Shochet, Lilach Israeli-Shani, Matthew Koslow, et al.
Pageof 700